-
EP3299368
European procedure
Extract from the Register of European Patents
EP About this file: EP3299368
| EP3299368 - NOVEL AMINO PYRIMIDINE DERIVATIVES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.01.2021 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 24.01.2020 | ||
| Former | Grant of patent is intended Status updated on 19.09.2019 | ||
| Former | Examination is in progress Status updated on 11.01.2019 | ||
| Former | Request for examination was made Status updated on 05.10.2018 | ||
| Former | The application has been published Status updated on 23.02.2018 | Most recent event Tooltip | 01.01.2021 | No opposition filed within time limit | published on 03.02.2021 [2021/05] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2018/13] | Inventor(s) | 01 /
Angst, Daniela Novartis Pharma AG Postfach 4002 Basel / CH | 02 /
Gessier, François Novartis Pharma AG Postfach 4002 Basel / CH | 03 /
Vulpetti, Anna Novartis Pharma AG Postfach 4002 Basel / CH | [2018/13] | Representative(s) | von Sprecher, Georg Novartis Pharma AG Patent Department 4002 Basel / CH | [2018/13] | Application number, filing date | 17191467.4 | 28.11.2014 | [2018/13] | Priority number, date | EP20130195081 | 29.11.2013 Original published format: EP 13195081 | [2018/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3299368 | Date: | 28.03.2018 | Language: | EN | [2018/13] | Type: | B1 Patent specification | No.: | EP3299368 | Date: | 26.02.2020 | Language: | EN | [2020/09] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 19.02.2018 | Classification | IPC: | C07D403/12, C07D401/14, C07D401/10, C07D401/12, C07D405/12, C07D239/47, A61P29/00, A61P35/02, A61K31/505, A61K31/506 | [2019/36] | CPC: |
C07D239/47 (EP,KR,US);
A61K31/505 (EP,US);
A61K31/506 (EP,US);
A61K31/513 (KR);
A61P29/00 (EP,US);
A61P35/00 (KR);
A61P35/02 (EP,US);
C07D401/10 (EP,US);
C07D401/12 (EP,US);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D405/12 (EP,US);
Y02P20/55 (EP)
(-)
|
| Former IPC [2018/13] | C07D403/12, C07D401/14, C07D401/10, C07D401/12, C07D405/12, C07D239/47, A61P29/00, A61P35/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/45] |
| Former [2018/13] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | NEUARTIGE AMINOPYRIMIDINDERIVATE | [2018/13] | English: | NOVEL AMINO PYRIMIDINE DERIVATIVES | [2018/13] | French: | NOUVEAUX DÉRIVÉS D'AMINO PYRIMIDINE | [2018/13] | Examination procedure | 11.09.2018 | Amendment by applicant (claims and/or description) | 28.09.2018 | Examination requested [2018/45] | 28.09.2018 | Date on which the examining division has become responsible | 10.01.2019 | Despatch of a communication from the examining division (Time limit: M04) | 07.05.2019 | Reply to a communication from the examining division | 20.09.2019 | Communication of intention to grant the patent | 17.01.2020 | Fee for grant paid | 17.01.2020 | Fee for publishing/printing paid | 17.01.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP14821285.5 / EP3074386 | Divisional application(s) | EP20158961.1 / EP3689865 | EP23161775.4 | Opposition(s) | 27.11.2020 | No opposition filed within time limit [2021/05] | Fees paid | Renewal fee | 15.01.2018 | Renewal fee patent year 03 | 13.11.2017 | Renewal fee patent year 04 | 14.11.2018 | Renewal fee patent year 05 | 14.11.2019 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 26.02.2020 | [2020/48] | Documents cited: | Search | [A]WO2010100070 (HOFFMANN LA ROCHE [CH], et al) [A] 1-16* claim 1 *; | [A]WO2013083666 (HOFFMANN LA ROCHE [CH], et al) [A] 1-16 * claim 1 * | by applicant | WO0238561 | WO02102790 | WO03082859 | WO2004052359 | WO2004078163 | WO2005000833 | WO2005066156 | WO2010000633 | - Remington's Pharmaceutical Sciences, Mack Printing Company, (19900000), pages 1289 - 1329 |